X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,850351-   
Low Rs2,966253-   
Sales per share (Unadj.) Rs332.3104.4-  
Earnings per share (Unadj.) Rs44.3-26.3-  
Cash flow per share (Unadj.) Rs47.2-21.8-  
Dividends per share (Unadj.) Rs50.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs202.781.9-  
Shares outstanding (eoy) m84.70168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x10.32.9 354.4%   
Avg P/E ratio x76.9-11.5 -670.0%  
P/CF ratio (eoy) x72.2-13.9 -520.8%  
Price / Book Value ratio x16.83.7 456.0%  
Dividend payout %112.90-   
Avg Mkt Cap Rs m288,64350,974 566.3%   
No. of employees `0004.64.3 107.4%   
Total wages/salary Rs m4,4343,199 138.6%   
Avg. sales/employee Rs Th6,104.54,103.8 148.8%   
Avg. wages/employee Rs Th961.6745.2 129.0%   
Avg. net profit/employee Rs Th813.7-1,034.1 -78.7%   
INCOME DATA
Net Sales Rs m28,14817,618 159.8%  
Other income Rs m1,218123 987.5%   
Total revenues Rs m29,36617,741 165.5%   
Gross profit Rs m4,774-3,053 -156.4%  
Depreciation Rs m248760 32.6%   
Interest Rs m0477 0.0%   
Profit before tax Rs m5,744-4,167 -137.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m260-   
Tax Rs m2,018260 775.0%   
Profit after tax Rs m3,752-4,439 -84.5%  
Gross profit margin %17.0-17.3 -97.9%  
Effective tax rate %35.1-6.2 -562.2%   
Net profit margin %13.3-25.2 -52.9%  
BALANCE SHEET DATA
Current assets Rs m21,46212,903 166.3%   
Current liabilities Rs m10,5367,260 145.1%   
Net working cap to sales %38.832.0 121.2%  
Current ratio x2.01.8 114.6%  
Inventory Days Days68111 61.0%  
Debtors Days Days16124 13.2%  
Net fixed assets Rs m4,7177,521 62.7%   
Share capital Rs m84782 1,035.5%   
"Free" reserves Rs m16,3080-   
Net worth Rs m17,17113,828 124.2%   
Long term debt Rs m164,859 0.3%   
Total assets Rs m30,62026,122 117.2%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.90.7 136.3%   
Return on assets %12.3-15.2 -80.8%  
Return on equity %21.9-32.1 -68.1%  
Return on capital %33.6-19.8 -169.5%  
Exports to sales %00-   
Imports to sales %15.10-   
Net fx Rs m-7,8010-   
CASH FLOW
From Operations Rs m1,3861,504 92.1%  
From Investments Rs m5,010-462 -1,084.9%  
From Financial Activity Rs m-6,3834,410 -144.7%  
Net Cashflow Rs m125,452 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.84 Rs / ZAR

Compare GSK PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: PFIZER  J.B.CHEMICALS  ELDER PHARMA  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 23, 2017 11:58 AM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS